SCHEMBL3357679

SCHEMBL3357679

CN1CCC(N2CCc3cc([N+](=O)[O-])ccc32)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.50
CYP3A4 P08684 2/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2C9 P11712 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.47
ACHE P22303 1/20 0.44
NOS3 P29474 2/20 0.44
NOS1 P29475 2/20 0.44
NOS2 P35228 2/20 0.44
SIRT6 Q8N6T7 1/20 0.42
ALDH1A1 P00352 8/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 4/20 0.42
HTT P42858 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GAA P10253 1/20 0.42
CYP1A2 P05177 1/20 0.42
MAPT P10636 2/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL429286 0.89 HTR1A (0.48) DPP4CYP3A4CYP2C19CYP2C9ACHE
SCHEMBL1868367 0.85 DPP4 (0.54) DPP4CYP3A4CYP2C19CYP2C9SIRT2
SCHEMBL2675840 0.81 ACHE (0.47) CYP3A4CYP2C19SIRT2ACHEALDH1A1
SCHEMBL31378746 0.78 ROCK1 (0.44) DPP4CYP3A4CYP2C19CYP2C9ACHE
SCHEMBL3885369 0.78 SIRT2 (0.55) CYP3A4CYP2C19CYP2C9SIRT2SIRT6
SCHEMBL27778275 0.78 ACHE (0.42) CYP3A4CYP2C19SIRT2ACHESIRT6
SCHEMBL30612412 0.77 ACHE (0.44) ACHESIRT6ALDH1A1POLBKMT2A
SCHEMBL2675961 0.76 NOS1 (0.48) DPP4NOS3NOS1NOS2HTR1A
SCHEMBL6125256 0.76 NOS1 (0.51) NOS3NOS1NOS2HTR1A
SCHEMBL2675742 0.76 NOS1 (0.51) NOS3NOS1NOS2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed